Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-495

Hi Reg,

I dont think a takeover offer of any description would be a wise move for SH's to support. SI and his team over the past 10 years or so, that I have been involved, have gained expertise and knowledge that I think, unfortunately, far outstrip the FDA knowledge or that of their regulators? As you would expect I suppose with people who are working with, what was the buzz word at one time? "disruptive technology"

I know there is a thread "CEO Itesco has to go" though I haven't bothered reading any of it. Tell me if it is worth a read? Once FDA approval is granted it will just be the start line in my opinion and to have some "content free" management take over would be ludicrous? but in the age of the "orange idiot" anything is possible I suppose.

Their will be plenty of short sighted people though after a quick buck who would be stupid enough to support it I suppose.

Cheers